Jacobs Levy Equity Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$177K Buy
+23,199
New +$177K ﹤0.01% 923
2024
Q4
Sell
-39,521
Closed -$433K 1028
2024
Q3
$433K Sell
39,521
-44,153
-53% -$448K ﹤0.01% 852
2024
Q2
$753K Sell
83,674
-49,521
-37% -$345K ﹤0.01% 790
2024
Q1
$1.09M Buy
+133,195
New +$1.09M ﹤0.01% 701

Other funds holding REPL

Jacobs Levy Equity Management's REPL Position: Q1 2026 in Review

Jacobs Levy Equity Management opened a new position in Replimune Group (REPL) in Q1 2026: 23,199 shares worth $177K. The stake represents ﹤0.01% of the portfolio and ranks #923 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in REPL as recently as Q3 2024.

Jacobs Levy Equity Management first reported a position in REPL in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.09M in Q1 2024. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Jacobs Levy Equity Management held 23,199 shares of Replimune Group worth $177K as of Q1 2026.
  • Replimune Group was a new Jacobs Levy Equity Management position in Q1 2026.
  • Replimune Group made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #923 holding.
  • Jacobs Levy Equity Management first reported a position in Replimune Group in Q1 2024 and has held it in 4 quarters since.
  • Jacobs Levy Equity Management's Replimune Group position peaked at $1.09M in Q1 2024.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.